KELLANOVA (K)
(Delayed Data from NYSE)
$80.64 USD
+0.05 (0.06%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $80.64 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$80.64 USD
+0.05 (0.06%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $80.64 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth F Momentum F VGM
Zacks News
Kellogg (K) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Kellogg (K) delivered earnings and revenue surprises of 12.38% and 6.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for MOAT
Hillenbrand (HI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Hillenbrand (HI) delivered earnings and revenue surprises of 6.98% and 1.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
B&G Foods (BGS) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Higher product demand and a solid brand portfolio are likely to aid B&G Foods' (BGS) second-quarter 2022 results. However, cost inflation is a major headwind.
Is a Surprise Coming for Kellogg Company (K) This Earnings Season?
by Zacks Equity Research
Kellogg Company (K) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Factors Likely to Decide Nu Skin's (NUS) Fate in Q2 Earnings
by Zacks Equity Research
Nu Skin's (NUS) Q2 results are likely to reflect the impacts of COVID-led headwinds in Mainland China, the ongoing conflict between Russia and Ukraine, and the global economic downturn.
Factors to Influence Monster Beverage's (MNST) Q2 Earnings
by Zacks Equity Research
Monster Beverage's (MNST) Q2 results are expected to reflect gains from strong consumer demand for energy drinks, innovation and product launches amid a high cost environment.
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MOAT
Kellogg's Q2 Preview: 6th Consecutive EPS Beat Inbound?
by Derek Lewis
Kellogg shares have been blistering hot year-to-date, increasing nearly 17% in value and crushing the S&P 500's performance.
Sysco (SYY) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Sysco (SYY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kellogg (K) Readies for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Kellogg's (K) second-quarter 2022 results are likely to reflect gains from the EMEA region's strength and the snacks business, whereas cost inflation is likely to have been a challenge.
Clorox (CLX) Readies for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Clorox's (CLX) fourth-quarter fiscal 2022 results are likely to reflect gains from the IGNITE strategy and pricing actions, whereas elevated cost concerns are likely to have affected profits.
Post Holdings (POST) Queued for Q3 Earnings: Things to Note
by Zacks Equity Research
Post Holdings' (POST) Q3 performance is likely to reflect adverse impacts from higher raw material, freight and manufacturing costs. Also, supply chain disruptions might be a concern.
Medifast (MED) Readies for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Medifast's (MED) second-quarter 2022 results are likely to reflect gains from its OPTAVIA lifestyle solution and coaching support system, while escalated costs might have been a concern.
What's in Store for Service Corporation (SCI) in Q2 Earnings?
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2022 results are likely to reflect higher funeral revenues, whereas elevated costs might have been a deterrent.
Factors Likely to Decide Carter's (CRI) Fate in Q2 Earnings
by Zacks Equity Research
Carter's (CRI) second-quarter results are likely to reflect the impacts of weak retail sales, high freight costs and supply chain issues. However, online strength and improved price realization act as upsides.
Kellogg (K) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Kellogg (K) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors to Influence Procter & Gamble (PG) in Q4 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q4 results are expected to reflect gains from strong demand for cleaning products and improved productivity, amid rising input costs and supply- chain woes.
Factors to Decide the Fate of Colgate (CL) in Q2 Earnings
by Zacks Equity Research
Colgate's (CL) Q2 results are expected to reflect gains from strong consumer demand, innovation, premiumization, digital growth and robust pricing actions amid rising raw material and logistic costs.
Here's How FEMSA (FMX) is Poised Just Ahead of Q2 Earnings
by Zacks Equity Research
FEMSA's (FMX) Q2 results are expected to reflect gains from strength across businesses, owing to effective growth strategies and robust demand across markets amid supply-chain and inflation woes.
Mondelez (MDLZ) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Mondelez (MDLZ) delivered earnings and revenue surprises of 4.69% and 6.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Kellogg (K) Could Beat Earnings Estimates Again
by Zacks Equity Research
Kellogg (K) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Kellogg (K) Stock Up 7% in 3 Months: Will the Momentum Last?
by Zacks Equity Research
Kellogg Company (K) has been benefiting from its brands and solid performance in the Europe, Middle East and Africa region. However, supply-chain hurdles are a concern.
3 Stocks up Double-Digit Percentages in 2022
by Derek Lewis
There have been a few bright spots in this volatility-packed market, and believe it or not, there are stocks out there up double-digit percentages year-to-date.
Company News for Jun 22, 2022
by Zacks Equity Research
Companies in The News Are: K, SAVE, JBLU, LEN, AMD